- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Bridge Biotherapeutics terminates collaboration agreement with Boehringer

Under the latest deal, Bridge Biotherapeutics will regain all rights to BBT-877. Credit: © Boehringer Ingelheim.